Cipher Reports Financial and Operational Results for Q1 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cipher Pharma (CPHR) Reports Q1 EPS of $0.12
May 13, 2015 7:10 AM EDTCipher Pharma (NASDAQ: CPHR) reported Q1 EPS of $0.12, versus $0.15 reported last year. Revenue for the quarter came in at $9.18 million, versus $7.88 million reported last year.
For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.
... More